img

Global Dry Eye Disease Drug Market Research Report 2024

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Dry Eye Disease Drug Market Research Report 2024

Dry eye syndrome (DES), also known as keratoconjunctivitis sicca (KCS), is the condition of having dry eyes. Other associated symptoms include irritation, redness, discharge, and easily fatigued eyes. Blurred vision may also occur. The symptoms can range from mild and occasional to severe and continuous. Scarring of the cornea may occur in some cases without treatment.
According to Mr Accuracy reports new survey, global Dry Eye Disease Drug market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Dry Eye Disease Drug market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Dry Eye Disease Drug market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Allergan
Alcon
Novartis
Santen Pharma
Johnson & Johnson
Bausch & Lomb
Thea pharmaceuticals
URSAPHARM
SIMILASAN
Akorn
United Laboratories
Sun Pharmaceutical
Jianfeng Group
Segment by Type
Artificial Tears
Anti-inflammatory Drugs
Other

Segment by Application


Hospital
Retail Pharmacy
Others

Consumption by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Dry Eye Disease Drug report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source

Table of Content

1 Dry Eye Disease Drug Market Overview
1.1 Product Overview and Scope of Dry Eye Disease Drug
1.2 Dry Eye Disease Drug Segment by Type
1.2.1 Global Dry Eye Disease Drug Market Value Comparison by Type (2024-2034)
1.2.2 Artificial Tears
1.2.3 Anti-inflammatory Drugs
1.2.4 Other
1.3 Dry Eye Disease Drug Segment by Application
1.3.1 Global Dry Eye Disease Drug Market Value by Application: (2024-2034)
1.3.2 Hospital
1.3.3 Retail Pharmacy
1.3.4 Others
1.4 Global Dry Eye Disease Drug Market Size Estimates and Forecasts
1.4.1 Global Dry Eye Disease Drug Revenue 2018-2029
1.4.2 Global Dry Eye Disease Drug Sales 2018-2029
1.4.3 Global Dry Eye Disease Drug Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Dry Eye Disease Drug Market Competition by Manufacturers
2.1 Global Dry Eye Disease Drug Sales Market Share by Manufacturers (2018-2024)
2.2 Global Dry Eye Disease Drug Revenue Market Share by Manufacturers (2018-2024)
2.3 Global Dry Eye Disease Drug Average Price by Manufacturers (2018-2024)
2.4 Global Dry Eye Disease Drug Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of Dry Eye Disease Drug, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Dry Eye Disease Drug, Product Type & Application
2.7 Dry Eye Disease Drug Market Competitive Situation and Trends
2.7.1 Dry Eye Disease Drug Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Dry Eye Disease Drug Players Market Share by Revenue
2.7.3 Global Dry Eye Disease Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Dry Eye Disease Drug Retrospective Market Scenario by Region
3.1 Global Dry Eye Disease Drug Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Dry Eye Disease Drug Global Dry Eye Disease Drug Sales by Region: 2018-2029
3.2.1 Global Dry Eye Disease Drug Sales by Region: 2018-2024
3.2.2 Global Dry Eye Disease Drug Sales by Region: 2024-2029
3.3 Global Dry Eye Disease Drug Global Dry Eye Disease Drug Revenue by Region: 2018-2029
3.3.1 Global Dry Eye Disease Drug Revenue by Region: 2018-2024
3.3.2 Global Dry Eye Disease Drug Revenue by Region: 2024-2029
3.4 North America Dry Eye Disease Drug Market Facts & Figures by Country
3.4.1 North America Dry Eye Disease Drug Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Dry Eye Disease Drug Sales by Country (2018-2029)
3.4.3 North America Dry Eye Disease Drug Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Dry Eye Disease Drug Market Facts & Figures by Country
3.5.1 Europe Dry Eye Disease Drug Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Dry Eye Disease Drug Sales by Country (2018-2029)
3.5.3 Europe Dry Eye Disease Drug Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Dry Eye Disease Drug Market Facts & Figures by Country
3.6.1 Asia Pacific Dry Eye Disease Drug Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Dry Eye Disease Drug Sales by Country (2018-2029)
3.6.3 Asia Pacific Dry Eye Disease Drug Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Dry Eye Disease Drug Market Facts & Figures by Country
3.7.1 Latin America Dry Eye Disease Drug Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Dry Eye Disease Drug Sales by Country (2018-2029)
3.7.3 Latin America Dry Eye Disease Drug Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Dry Eye Disease Drug Market Facts & Figures by Country
3.8.1 Middle East and Africa Dry Eye Disease Drug Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Dry Eye Disease Drug Sales by Country (2018-2029)
3.8.3 Middle East and Africa Dry Eye Disease Drug Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Dry Eye Disease Drug Sales by Type (2018-2029)
4.1.1 Global Dry Eye Disease Drug Sales by Type (2018-2024)
4.1.2 Global Dry Eye Disease Drug Sales by Type (2024-2029)
4.1.3 Global Dry Eye Disease Drug Sales Market Share by Type (2018-2029)
4.2 Global Dry Eye Disease Drug Revenue by Type (2018-2029)
4.2.1 Global Dry Eye Disease Drug Revenue by Type (2018-2024)
4.2.2 Global Dry Eye Disease Drug Revenue by Type (2024-2029)
4.2.3 Global Dry Eye Disease Drug Revenue Market Share by Type (2018-2029)
4.3 Global Dry Eye Disease Drug Price by Type (2018-2029)
5 Segment by Application
5.1 Global Dry Eye Disease Drug Sales by Application (2018-2029)
5.1.1 Global Dry Eye Disease Drug Sales by Application (2018-2024)
5.1.2 Global Dry Eye Disease Drug Sales by Application (2024-2029)
5.1.3 Global Dry Eye Disease Drug Sales Market Share by Application (2018-2029)
5.2 Global Dry Eye Disease Drug Revenue by Application (2018-2029)
5.2.1 Global Dry Eye Disease Drug Revenue by Application (2018-2024)
5.2.2 Global Dry Eye Disease Drug Revenue by Application (2024-2029)
5.2.3 Global Dry Eye Disease Drug Revenue Market Share by Application (2018-2029)
5.3 Global Dry Eye Disease Drug Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Allergan
6.1.1 Allergan Corporation Information
6.1.2 Allergan Description and Business Overview
6.1.3 Allergan Dry Eye Disease Drug Sales, Revenue and Gross Margin (2018-2024)
6.1.4 Allergan Dry Eye Disease Drug Product Portfolio
6.1.5 Allergan Recent Developments/Updates
6.2 Alcon
6.2.1 Alcon Corporation Information
6.2.2 Alcon Description and Business Overview
6.2.3 Alcon Dry Eye Disease Drug Sales, Revenue and Gross Margin (2018-2024)
6.2.4 Alcon Dry Eye Disease Drug Product Portfolio
6.2.5 Alcon Recent Developments/Updates
6.3 Novartis
6.3.1 Novartis Corporation Information
6.3.2 Novartis Description and Business Overview
6.3.3 Novartis Dry Eye Disease Drug Sales, Revenue and Gross Margin (2018-2024)
6.3.4 Novartis Dry Eye Disease Drug Product Portfolio
6.3.5 Novartis Recent Developments/Updates
6.4 Santen Pharma
6.4.1 Santen Pharma Corporation Information
6.4.2 Santen Pharma Description and Business Overview
6.4.3 Santen Pharma Dry Eye Disease Drug Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Santen Pharma Dry Eye Disease Drug Product Portfolio
6.4.5 Santen Pharma Recent Developments/Updates
6.5 Johnson & Johnson
6.5.1 Johnson & Johnson Corporation Information
6.5.2 Johnson & Johnson Description and Business Overview
6.5.3 Johnson & Johnson Dry Eye Disease Drug Sales, Revenue and Gross Margin (2018-2024)
6.5.4 Johnson & Johnson Dry Eye Disease Drug Product Portfolio
6.5.5 Johnson & Johnson Recent Developments/Updates
6.6 Bausch & Lomb
6.6.1 Bausch & Lomb Corporation Information
6.6.2 Bausch & Lomb Description and Business Overview
6.6.3 Bausch & Lomb Dry Eye Disease Drug Sales, Revenue and Gross Margin (2018-2024)
6.6.4 Bausch & Lomb Dry Eye Disease Drug Product Portfolio
6.6.5 Bausch & Lomb Recent Developments/Updates
6.7 Thea pharmaceuticals
6.6.1 Thea pharmaceuticals Corporation Information
6.6.2 Thea pharmaceuticals Description and Business Overview
6.6.3 Thea pharmaceuticals Dry Eye Disease Drug Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Thea pharmaceuticals Dry Eye Disease Drug Product Portfolio
6.7.5 Thea pharmaceuticals Recent Developments/Updates
6.8 URSAPHARM
6.8.1 URSAPHARM Corporation Information
6.8.2 URSAPHARM Description and Business Overview
6.8.3 URSAPHARM Dry Eye Disease Drug Sales, Revenue and Gross Margin (2018-2024)
6.8.4 URSAPHARM Dry Eye Disease Drug Product Portfolio
6.8.5 URSAPHARM Recent Developments/Updates
6.9 SIMILASAN
6.9.1 SIMILASAN Corporation Information
6.9.2 SIMILASAN Description and Business Overview
6.9.3 SIMILASAN Dry Eye Disease Drug Sales, Revenue and Gross Margin (2018-2024)
6.9.4 SIMILASAN Dry Eye Disease Drug Product Portfolio
6.9.5 SIMILASAN Recent Developments/Updates
6.10 Akorn
6.10.1 Akorn Corporation Information
6.10.2 Akorn Description and Business Overview
6.10.3 Akorn Dry Eye Disease Drug Sales, Revenue and Gross Margin (2018-2024)
6.10.4 Akorn Dry Eye Disease Drug Product Portfolio
6.10.5 Akorn Recent Developments/Updates
6.11 United Laboratories
6.11.1 United Laboratories Corporation Information
6.11.2 United Laboratories Dry Eye Disease Drug Description and Business Overview
6.11.3 United Laboratories Dry Eye Disease Drug Sales, Revenue and Gross Margin (2018-2024)
6.11.4 United Laboratories Dry Eye Disease Drug Product Portfolio
6.11.5 United Laboratories Recent Developments/Updates
6.12 Sun Pharmaceutical
6.12.1 Sun Pharmaceutical Corporation Information
6.12.2 Sun Pharmaceutical Dry Eye Disease Drug Description and Business Overview
6.12.3 Sun Pharmaceutical Dry Eye Disease Drug Sales, Revenue and Gross Margin (2018-2024)
6.12.4 Sun Pharmaceutical Dry Eye Disease Drug Product Portfolio
6.12.5 Sun Pharmaceutical Recent Developments/Updates
6.13 Jianfeng Group
6.13.1 Jianfeng Group Corporation Information
6.13.2 Jianfeng Group Dry Eye Disease Drug Description and Business Overview
6.13.3 Jianfeng Group Dry Eye Disease Drug Sales, Revenue and Gross Margin (2018-2024)
6.13.4 Jianfeng Group Dry Eye Disease Drug Product Portfolio
6.13.5 Jianfeng Group Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Dry Eye Disease Drug Industry Chain Analysis
7.2 Dry Eye Disease Drug Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Dry Eye Disease Drug Production Mode & Process
7.4 Dry Eye Disease Drug Sales and Marketing
7.4.1 Dry Eye Disease Drug Sales Channels
7.4.2 Dry Eye Disease Drug Distributors
7.5 Dry Eye Disease Drug Customers
8 Dry Eye Disease Drug Market Dynamics
8.1 Dry Eye Disease Drug Industry Trends
8.2 Dry Eye Disease Drug Market Drivers
8.3 Dry Eye Disease Drug Market Challenges
8.4 Dry Eye Disease Drug Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Dry Eye Disease Drug Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Dry Eye Disease Drug Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Dry Eye Disease Drug Market Competitive Situation by Manufacturers in 2022
Table 4. Global Dry Eye Disease Drug Sales (K Units) of Key Manufacturers (2018-2024)
Table 5. Global Dry Eye Disease Drug Sales Market Share by Manufacturers (2018-2024)
Table 6. Global Dry Eye Disease Drug Revenue (US$ Million) by Manufacturers (2018-2024)
Table 7. Global Dry Eye Disease Drug Revenue Share by Manufacturers (2018-2024)
Table 8. Global Market Dry Eye Disease Drug Average Price (US$/Unit) of Key Manufacturers (2018-2024)
Table 9. Global Key Players of Dry Eye Disease Drug, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of Dry Eye Disease Drug, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Dry Eye Disease Drug, Product Type & Application
Table 12. Global Key Manufacturers of Dry Eye Disease Drug, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Dry Eye Disease Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dry Eye Disease Drug as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Dry Eye Disease Drug Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Dry Eye Disease Drug Sales by Region (2018-2024) & (K Units)
Table 18. Global Dry Eye Disease Drug Sales Market Share by Region (2018-2024)
Table 19. Global Dry Eye Disease Drug Sales by Region (2024-2029) & (K Units)
Table 20. Global Dry Eye Disease Drug Sales Market Share by Region (2024-2029)
Table 21. Global Dry Eye Disease Drug Revenue by Region (2018-2024) & (US$ Million)
Table 22. Global Dry Eye Disease Drug Revenue Market Share by Region (2018-2024)
Table 23. Global Dry Eye Disease Drug Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Dry Eye Disease Drug Revenue Market Share by Region (2024-2029)
Table 25. North America Dry Eye Disease Drug Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Dry Eye Disease Drug Sales by Country (2018-2024) & (K Units)
Table 27. North America Dry Eye Disease Drug Sales by Country (2024-2029) & (K Units)
Table 28. North America Dry Eye Disease Drug Revenue by Country (2018-2024) & (US$ Million)
Table 29. North America Dry Eye Disease Drug Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Dry Eye Disease Drug Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Dry Eye Disease Drug Sales by Country (2018-2024) & (K Units)
Table 32. Europe Dry Eye Disease Drug Sales by Country (2024-2029) & (K Units)
Table 33. Europe Dry Eye Disease Drug Revenue by Country (2018-2024) & (US$ Million)
Table 34. Europe Dry Eye Disease Drug Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Dry Eye Disease Drug Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Dry Eye Disease Drug Sales by Region (2018-2024) & (K Units)
Table 37. Asia Pacific Dry Eye Disease Drug Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Dry Eye Disease Drug Revenue by Region (2018-2024) & (US$ Million)
Table 39. Asia Pacific Dry Eye Disease Drug Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Dry Eye Disease Drug Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Dry Eye Disease Drug Sales by Country (2018-2024) & (K Units)
Table 42. Latin America Dry Eye Disease Drug Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Dry Eye Disease Drug Revenue by Country (2018-2024) & (US$ Million)
Table 44. Latin America Dry Eye Disease Drug Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Dry Eye Disease Drug Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Dry Eye Disease Drug Sales by Country (2018-2024) & (K Units)
Table 47. Middle East & Africa Dry Eye Disease Drug Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Dry Eye Disease Drug Revenue by Country (2018-2024) & (US$ Million)
Table 49. Middle East & Africa Dry Eye Disease Drug Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Dry Eye Disease Drug Sales (K Units) by Type (2018-2024)
Table 51. Global Dry Eye Disease Drug Sales (K Units) by Type (2024-2029)
Table 52. Global Dry Eye Disease Drug Sales Market Share by Type (2018-2024)
Table 53. Global Dry Eye Disease Drug Sales Market Share by Type (2024-2029)
Table 54. Global Dry Eye Disease Drug Revenue (US$ Million) by Type (2018-2024)
Table 55. Global Dry Eye Disease Drug Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Dry Eye Disease Drug Revenue Market Share by Type (2018-2024)
Table 57. Global Dry Eye Disease Drug Revenue Market Share by Type (2024-2029)
Table 58. Global Dry Eye Disease Drug Price (US$/Unit) by Type (2018-2024)
Table 59. Global Dry Eye Disease Drug Price (US$/Unit) by Type (2024-2029)
Table 60. Global Dry Eye Disease Drug Sales (K Units) by Application (2018-2024)
Table 61. Global Dry Eye Disease Drug Sales (K Units) by Application (2024-2029)
Table 62. Global Dry Eye Disease Drug Sales Market Share by Application (2018-2024)
Table 63. Global Dry Eye Disease Drug Sales Market Share by Application (2024-2029)
Table 64. Global Dry Eye Disease Drug Revenue (US$ Million) by Application (2018-2024)
Table 65. Global Dry Eye Disease Drug Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Dry Eye Disease Drug Revenue Market Share by Application (2018-2024)
Table 67. Global Dry Eye Disease Drug Revenue Market Share by Application (2024-2029)
Table 68. Global Dry Eye Disease Drug Price (US$/Unit) by Application (2018-2024)
Table 69. Global Dry Eye Disease Drug Price (US$/Unit) by Application (2024-2029)
Table 70. Allergan Corporation Information
Table 71. Allergan Description and Business Overview
Table 72. Allergan Dry Eye Disease Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 73. Allergan Dry Eye Disease Drug Product
Table 74. Allergan Recent Developments/Updates
Table 75. Alcon Corporation Information
Table 76. Alcon Description and Business Overview
Table 77. Alcon Dry Eye Disease Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 78. Alcon Dry Eye Disease Drug Product
Table 79. Alcon Recent Developments/Updates
Table 80. Novartis Corporation Information
Table 81. Novartis Description and Business Overview
Table 82. Novartis Dry Eye Disease Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 83. Novartis Dry Eye Disease Drug Product
Table 84. Novartis Recent Developments/Updates
Table 85. Santen Pharma Corporation Information
Table 86. Santen Pharma Description and Business Overview
Table 87. Santen Pharma Dry Eye Disease Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 88. Santen Pharma Dry Eye Disease Drug Product
Table 89. Santen Pharma Recent Developments/Updates
Table 90. Johnson & Johnson Corporation Information
Table 91. Johnson & Johnson Description and Business Overview
Table 92. Johnson & Johnson Dry Eye Disease Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 93. Johnson & Johnson Dry Eye Disease Drug Product
Table 94. Johnson & Johnson Recent Developments/Updates
Table 95. Bausch & Lomb Corporation Information
Table 96. Bausch & Lomb Description and Business Overview
Table 97. Bausch & Lomb Dry Eye Disease Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 98. Bausch & Lomb Dry Eye Disease Drug Product
Table 99. Bausch & Lomb Recent Developments/Updates
Table 100. Thea pharmaceuticals Corporation Information
Table 101. Thea pharmaceuticals Description and Business Overview
Table 102. Thea pharmaceuticals Dry Eye Disease Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 103. Thea pharmaceuticals Dry Eye Disease Drug Product
Table 104. Thea pharmaceuticals Recent Developments/Updates
Table 105. URSAPHARM Corporation Information
Table 106. URSAPHARM Description and Business Overview
Table 107. URSAPHARM Dry Eye Disease Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 108. URSAPHARM Dry Eye Disease Drug Product
Table 109. URSAPHARM Recent Developments/Updates
Table 110. SIMILASAN Corporation Information
Table 111. SIMILASAN Description and Business Overview
Table 112. SIMILASAN Dry Eye Disease Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 113. SIMILASAN Dry Eye Disease Drug Product
Table 114. SIMILASAN Recent Developments/Updates
Table 115. Akorn Corporation Information
Table 116. Akorn Description and Business Overview
Table 117. Akorn Dry Eye Disease Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 118. Akorn Dry Eye Disease Drug Product
Table 119. Akorn Recent Developments/Updates
Table 120. United Laboratories Corporation Information
Table 121. United Laboratories Description and Business Overview
Table 122. United Laboratories Dry Eye Disease Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 123. United Laboratories Dry Eye Disease Drug Product
Table 124. United Laboratories Recent Developments/Updates
Table 125. Sun Pharmaceutical Corporation Information
Table 126. Sun Pharmaceutical Description and Business Overview
Table 127. Sun Pharmaceutical Dry Eye Disease Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 128. Sun Pharmaceutical Dry Eye Disease Drug Product
Table 129. Sun Pharmaceutical Recent Developments/Updates
Table 130. Jianfeng Group Corporation Information
Table 131. Jianfeng Group Description and Business Overview
Table 132. Jianfeng Group Dry Eye Disease Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 133. Jianfeng Group Dry Eye Disease Drug Product
Table 134. Jianfeng Group Recent Developments/Updates
Table 135. Key Raw Materials Lists
Table 136. Raw Materials Key Suppliers Lists
Table 137. Dry Eye Disease Drug Distributors List
Table 138. Dry Eye Disease Drug Customers List
Table 139. Dry Eye Disease Drug Market Trends
Table 140. Dry Eye Disease Drug Market Drivers
Table 141. Dry Eye Disease Drug Market Challenges
Table 142. Dry Eye Disease Drug Market Restraints
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Dry Eye Disease Drug
Figure 2. Global Dry Eye Disease Drug Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Dry Eye Disease Drug Market Share by Type in 2022 & 2029
Figure 4. Artificial Tears Product Picture
Figure 5. Anti-inflammatory Drugs Product Picture
Figure 6. Other Product Picture
Figure 7. Global Dry Eye Disease Drug Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 8. Global Dry Eye Disease Drug Market Share by Application in 2022 & 2029
Figure 9. Hospital
Figure 10. Retail Pharmacy
Figure 11. Others
Figure 12. Global Dry Eye Disease Drug Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Dry Eye Disease Drug Market Size (2018-2029) & (US$ Million)
Figure 14. Global Dry Eye Disease Drug Sales (2018-2029) & (K Units)
Figure 15. Global Dry Eye Disease Drug Average Price (US$/Unit) & (2018-2029)
Figure 16. Dry Eye Disease Drug Report Years Considered
Figure 17. Dry Eye Disease Drug Sales Share by Manufacturers in 2022
Figure 18. Global Dry Eye Disease Drug Revenue Share by Manufacturers in 2022
Figure 19. The Global 5 and 10 Largest Dry Eye Disease Drug Players: Market Share by Revenue in 2022
Figure 20. Dry Eye Disease Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 21. Global Dry Eye Disease Drug Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 22. North America Dry Eye Disease Drug Sales Market Share by Country (2018-2029)
Figure 23. North America Dry Eye Disease Drug Revenue Market Share by Country (2018-2029)
Figure 24. United States Dry Eye Disease Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 25. Canada Dry Eye Disease Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 26. Europe Dry Eye Disease Drug Sales Market Share by Country (2018-2029)
Figure 27. Europe Dry Eye Disease Drug Revenue Market Share by Country (2018-2029)
Figure 28. Germany Dry Eye Disease Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. France Dry Eye Disease Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. U.K. Dry Eye Disease Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Italy Dry Eye Disease Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Russia Dry Eye Disease Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. Asia Pacific Dry Eye Disease Drug Sales Market Share by Region (2018-2029)
Figure 34. Asia Pacific Dry Eye Disease Drug Revenue Market Share by Region (2018-2029)
Figure 35. China Dry Eye Disease Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. Japan Dry Eye Disease Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. South Korea Dry Eye Disease Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. India Dry Eye Disease Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Australia Dry Eye Disease Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. China Taiwan Dry Eye Disease Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Indonesia Dry Eye Disease Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Thailand Dry Eye Disease Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Malaysia Dry Eye Disease Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Latin America Dry Eye Disease Drug Sales Market Share by Country (2018-2029)
Figure 45. Latin America Dry Eye Disease Drug Revenue Market Share by Country (2018-2029)
Figure 46. Mexico Dry Eye Disease Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Brazil Dry Eye Disease Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Argentina Dry Eye Disease Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Middle East & Africa Dry Eye Disease Drug Sales Market Share by Country (2018-2029)
Figure 50. Middle East & Africa Dry Eye Disease Drug Revenue Market Share by Country (2018-2029)
Figure 51. Turkey Dry Eye Disease Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. Saudi Arabia Dry Eye Disease Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. UAE Dry Eye Disease Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 54. Global Sales Market Share of Dry Eye Disease Drug by Type (2018-2029)
Figure 55. Global Revenue Market Share of Dry Eye Disease Drug by Type (2018-2029)
Figure 56. Global Dry Eye Disease Drug Price (US$/Unit) by Type (2018-2029)
Figure 57. Global Sales Market Share of Dry Eye Disease Drug by Application (2018-2029)
Figure 58. Global Revenue Market Share of Dry Eye Disease Drug by Application (2018-2029)
Figure 59. Global Dry Eye Disease Drug Price (US$/Unit) by Application (2018-2029)
Figure 60. Dry Eye Disease Drug Value Chain
Figure 61. Dry Eye Disease Drug Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries